ASCO GU 2026: Updates in renal cancer
Prof Licitra speaks with ecancertv at the IFHNOS 2016 session in Moscow about systemic therapies for head and neck cancers.
She describes efforts at integration of chemotherapy into treating local tumour indications, and surgical alternatives to chemo-radiation to reduce adverse events.
Considering developments in immuno-oncology, Prof Licitra anticipates early trials which are currently ongoing will soon provide clearer steps towards a multi-modality treatment of local cancers.
ASCO GU 2026: Updates in renal cancer
Best practice in precision medicine for prostate cancer
Key insights from lung cancer research at ASCO 2025
ELCC 2025: Latest in EGFR positive NSCLC
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma In Rwanda: The need for further research
GIST tumours and soft tissue sarcomas